Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacologic Treatment of Obesity in adults and its impact on comorbidities: 2024 Update and Position Statement of Specialists from the Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso) and the Brazilian Society of Endocrinology and Metabolism (SBEM).
Moreira RO, Valerio CM, Hohl A, Moulin C, Moura F, Trujilho FR, Gerchman F, Correa LL, Mancini MC, Melo ME, Lamounier RN, van de Sande-Lee S, Trujilho TDG, Miranda PAC, Halpern B. Moreira RO, et al. Arch Endocrinol Metab. 2024 Nov 25;68:e240422. doi: 10.20945/2359-4292-2024-0422. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39664998 Free PMC article. Review.
Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO).
Halpern B, Mancini MC, de Melo ME, Lamounier RN, Moreira RO, Carra MK, Kyle TK, Cercato C, Boguszewski CL. Halpern B, et al. Among authors: moreira ro. Arch Endocrinol Metab. 2022 Apr 28;66(2):139-151. doi: 10.20945/2359-3997000000465. Epub 2022 Apr 11. Arch Endocrinol Metab. 2022. PMID: 35420271 Free PMC article.
The new obesity classification based on weight history is not proposed as a guideline.
Halpern B, Mancini MC, de Melo ME, Lamounier RN, Moreira RO, Carra MK, Cercato C, Boguszewski CL. Halpern B, et al. Among authors: moreira ro. Arch Endocrinol Metab. 2022 Nov 17;66(6):936-937. doi: 10.20945/2359-3997000000571. Arch Endocrinol Metab. 2022. PMID: 36394490 Free PMC article. No abstract available.
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).
Moreira RO, Valerio CM, Villela-Nogueira CA, Cercato C, Gerchman F, Lottenberg AMP, Godoy-Matos AF, Oliveira RA, Brandão Mello CE, Álvares-da-Silva MR, Leite NC, Cotrim HP, Parisi ER, Silva GF, Miranda PAC, Halpern B, Pinto Oliveira C. Moreira RO, et al. Arch Endocrinol Metab. 2023 Nov 27;67(6):e230123. doi: 10.20945/2359-4292-2023-0123. Arch Endocrinol Metab. 2023. PMID: 38048417 Review.
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM).
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Bertoluci MC, et al. Among authors: moreira ro. Diabetol Metab Syndr. 2017 Jul 14;9:53. doi: 10.1186/s13098-017-0251-z. eCollection 2017. Diabetol Metab Syndr. 2017. PMID: 28725272 Free PMC article. Review.
2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes.
Bertoluci MC, Silva Júnior WS, Valente F, Araujo LR, Lyra R, de Castro JJ, Raposo JF, Miranda PAC, Boguszewski CL, Hohl A, Duarte R, Salles JEN, Silva-Nunes J, Dores J, Melo M, de Sá JR, Neves JS, Moreira RO, Malachias MVB, Lamounier RN, Malerbi DA, Calliari LE, Cardoso LM, Carvalho MR, Ferreira HJ, Nortadas R, Trujilho FR, Leitão CB, Simões JAR, Dos Reis MIN, Melo P, Marcelino M, Carvalho D. Bertoluci MC, et al. Among authors: moreira ro. Diabetol Metab Syndr. 2023 Jul 19;15(1):160. doi: 10.1186/s13098-023-01121-x. Diabetol Metab Syndr. 2023. PMID: 37468901 Free PMC article. Review.
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus.
Bertoluci MC, Salles JEN, Silva-Nunes J, Pedrosa HC, Moreira RO, da Silva Duarte RMC, da Costa Carvalho DM, Trujilho FR, Dos Santos Raposo JFC, Parente EB, Valente F, de Moura FF, Hohl A, Melo M, Araujo FGP, de Araújo Principe RMMC, Kupfer R, Costa E Forti A, Valerio CM, Ferreira HJ, Duarte JMS, Saraiva JFK, Rodacki M, Castelo MHCG, Monteiro MP, Branco PQ, de Matos PMP, de Melo Pereira de Magalhães PC, Betti RTB, Réa RR, Trujilho TDG, Pinto LCF, Leitão CB. Bertoluci MC, et al. Among authors: moreira ro. Diabetol Metab Syndr. 2020 May 24;12:45. doi: 10.1186/s13098-020-00551-1. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32489427 Free PMC article. Review.
74 results